CXCR3 and metabolic dysfunction-associated steatotic liver disease: CXCL10 and its homologous receptor CXCR3 are critical in the development of specific features of the NAFLD phenotype, wherein they are mainly involved in the induction of inflammation, regulation of adipogenesis and oxidative stress, and other related processes [58,59].